CD38 and COVID-19: Our early COVID-19 case study showed that both CD4+ T-follicular helper cells and activated CD38+HLA-DR+CD8+ T cells appeared in the patient’s blood at 3 d prior to recovery, suggesting that they played a part in the resolution of COVID-19 (13).